SPBC119.16c Antibody

What is SPBC119.16c and what cellular processes is it involved in?

SPBC119.16c is a protein in Schizosaccharomyces pombe (fission yeast) that has been studied in the context of cell cycle regulation and cellular growth pathways. This protein may be connected to regulatory mechanisms involving the Greatwall-Endosulfine-PP2A/B55 pathway, which plays crucial roles in G1 arrest under nitrogen starvation conditions . The specific function of SPBC119.16c should be investigated through experimental approaches such as genetic knockouts, localization studies, and protein-protein interaction analyses. When designing experiments to characterize this protein, researchers should consider its potential role in cell cycle checkpoints and its possible interactions with kinases and phosphatases that regulate cell division and growth.

What are the recommended protocols for using SPBC119.16c antibody in Western blot applications?

For Western blot detection using SPBC119.16c antibody, begin with protein extraction under denaturing conditions, followed by protein concentration determination. Prepare samples for SDS-PAGE protein electrophoresis using standard loading buffer protocols. After separation, transfer proteins to PVDF membranes using a semi-dry or wet transfer system . Block membranes with 5% non-fat milk or BSA in TBST for 1 hour at room temperature. Incubate with SPBC119.16c primary antibody (CSB-PA524261XA01SXV) at an optimized dilution (typically 1:1000 to 1:5000) in blocking solution overnight at 4°C. After washing with TBST, incubate with anti-mouse IgG-horseradish peroxidase conjugated secondary antibody . Following final washes, visualize using chemiluminescence detection. For optimization, titrate antibody concentrations and adjust incubation times based on signal-to-noise ratios observed in initial experiments.

How should I optimize protein extraction from S. pombe for SPBC119.16c detection?

Efficient protein extraction from S. pombe for SPBC119.16c detection requires specific techniques to overcome the robust cell wall. For denaturing conditions, collect cells during mid-log phase (OD600 ~0.5-0.8) and resuspend in lysis buffer containing 50 mM HEPES-KOH (pH 7.5), 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, and 0.1% sodium deoxycholate . Add protease inhibitors (complete protease inhibitor cocktail) and phosphatase inhibitors if phosphorylation states are relevant. Disrupt cells using glass beads in a bead beater with 30-second cycles followed by 30-second cooling periods, repeating 5-8 times . Centrifuge lysates at 13,000 × g for 15 minutes at 4°C to remove cell debris. Determine protein concentration using Bradford or BCA assay, adjusting to 1-2 mg/ml before proceeding to SDS-PAGE. This protocol enables efficient extraction while preserving protein integrity for subsequent antibody-based detection.

What controls should be included when using SPBC119.16c antibody for the first time?

When using SPBC119.16c antibody for the first time, include multiple controls to validate specificity and optimize experimental conditions. First, include a positive control using wild-type S. pombe strain 972 (ATCC 24843) lysate expressing SPBC119.16c . Second, include a negative control using extracts from a SPBC119.16c deletion mutant if available. Third, perform a peptide competition assay by pre-incubating the antibody with excess immunizing peptide before application to the membrane. Fourth, include loading controls such as anti-tubulin or anti-actin antibodies to normalize protein amounts. Fifth, consider using lysates from cells where SPBC119.16c is overexpressed to confirm band identity. Finally, test different antibody dilutions (e.g., 1:500, 1:1000, 1:2000) to determine optimal concentration. Document temperature, incubation time, and blocking conditions that yield the best signal-to-noise ratio for future reference.

How can I use SPBC119.16c antibody for studying protein-protein interactions in fission yeast?

To study protein-protein interactions involving SPBC119.16c, co-immunoprecipitation (co-IP) provides valuable insights. Begin by extracting proteins under non-denaturing conditions to preserve native complexes. Grow S. pombe cells to mid-log phase and harvest by centrifugation. Resuspend cells in IP buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100) with protease inhibitors . Lyse cells using glass beads in a bead beater with cooling intervals. After clearing lysates by centrifugation, perform pre-clearing with protein A/G beads. Incubate cleared lysates with SPBC119.16c antibody (approximately 5 μg) overnight at 4°C with gentle rotation. Add fresh protein A/G beads and incubate for 2-3 hours. Wash beads extensively with IP buffer, elute bound proteins, and analyze by SDS-PAGE followed by Western blotting with antibodies against suspected interaction partners. For validation, perform reciprocal co-IPs and consider advanced techniques like proximity ligation assays or bimolecular fluorescence complementation to confirm interactions in vivo.

What approaches can be used to validate SPBC119.16c antibody specificity in chromatin immunoprecipitation (ChIP) experiments?

Validating SPBC119.16c antibody specificity for ChIP requires a multi-faceted approach. First, perform Western blot analysis using the antibody to confirm it recognizes a single band of the expected molecular weight. Second, compare ChIP signals between wild-type cells and SPBC119.16c deletion mutants, expecting significant signal reduction in the mutant . Third, include an IgG isotype control antibody to establish background signal levels. Fourth, perform ChIP with tagged SPBC119.16c (e.g., with GFP or FLAG) and compare results using both anti-tag and anti-SPBC119.16c antibodies; overlapping signals strengthen validation. Fifth, include spike-in controls with chromatin from a different species (e.g., S. cerevisiae) for normalization across samples . Sixth, perform ChIP-qPCR on regions predicted to bind SPBC119.16c and control regions, verifying enrichment at target sites. Finally, confirm reproducibility by performing biological replicates and using statistical analysis to validate significant enrichment patterns.

How does SPBC119.16c expression change during cell cycle progression, and how can the antibody be used to track these changes?

Tracking SPBC119.16c expression throughout the cell cycle requires synchronized cell populations and quantitative antibody-based detection. Start by synchronizing S. pombe cultures using methods such as nitrogen starvation and release, hydroxyurea block and release, or lactose gradient centrifugation . Collect samples at regular intervals (every 15-20 minutes) covering at least one complete cell cycle. For each timepoint, prepare protein extracts and perform Western blot analysis using SPBC119.16c antibody. Quantify signal intensity by densitometry and normalize to a loading control that remains constant throughout the cell cycle. Plot normalized SPBC119.16c levels against time post-release to identify cycle-dependent fluctuations. Additionally, perform immunofluorescence microscopy using the same antibody to track protein localization changes during different cell cycle phases. Compare SPBC119.16c expression patterns with known cell cycle markers such as cyclins and confirm periodicity by monitoring cell morphology and DNA content via flow cytometry or DAPI staining.

How can I use mass spectrometry approaches to identify post-translational modifications of SPBC119.16c?

To identify post-translational modifications (PTMs) of SPBC119.16c, employ immunoprecipitation followed by mass spectrometry analysis. First, perform large-scale immunoprecipitation using SPBC119.16c antibody from S. pombe lysates under conditions that preserve PTMs (including phosphatase and deacetylase inhibitors). Alternatively, use GFP-TRAP purification if working with GFP-tagged SPBC119.16c . After immunoprecipitation, separate proteins by SDS-PAGE and excise the band corresponding to SPBC119.16c. Subject the gel slice to in-gel tryptic digestion, extracting peptides for LC-MS/MS analysis. Configure the mass spectrometer to detect common PTMs like phosphorylation, acetylation, methylation, and ubiquitination. Analyze MS data using software like MaxQuant or Proteome Discoverer with appropriate PTM search parameters . Validate identified PTMs using phospho-specific antibodies or by mutating modified residues to assess functional consequences. For phosphorylation site mapping, consider enriching phosphopeptides using titanium dioxide or immobilized metal affinity chromatography before MS analysis to increase detection sensitivity of low-abundance phosphorylation events.

How can I minimize background signal when using SPBC119.16c antibody in immunofluorescence microscopy?

To minimize background signal in immunofluorescence microscopy with SPBC119.16c antibody, implement a comprehensive optimization strategy. Begin by using freshly prepared fixatives (3-4% paraformaldehyde or methanol) and ensure complete cell permeabilization with appropriate detergents like Triton X-100 (0.1-0.5%). Block thoroughly with 5% BSA or normal serum from the same species as the secondary antibody for at least 1 hour. Dilute SPBC119.16c antibody optimally (test a range from 1:100 to 1:1000) and incubate overnight at 4°C in a humidified chamber. Include multiple washing steps with PBS containing 0.1% Tween-20, with at least 5 minutes per wash. Use highly cross-adsorbed secondary antibodies to prevent non-specific binding, and include DAPI counterstain to visualize nuclei. For negative controls, omit primary antibody or use pre-immune serum. Include wild-type and SPBC119.16c deletion strains to confirm specificity. If high background persists, try alternative fixation methods, increase blocking time, further dilute antibodies, or add 0.1-0.3M NaCl to washing buffers to disrupt non-specific ionic interactions.

What are the most common causes of inconsistent results when using SPBC119.16c antibody in Western blot analysis?

Inconsistent Western blot results with SPBC119.16c antibody typically stem from several key factors. First, variations in protein extraction efficiency can occur due to inconsistent cell lysis; standardize bead-beating cycles and ensure complete lysis under microscopic examination . Second, protein degradation during extraction may vary; use fresh protease inhibitors and maintain samples at 4°C throughout processing. Third, inconsistent protein loading leads to variable signal; validate concentration measurements using multiple methods (Bradford and direct A280 measurement) and confirm with stained membranes (Ponceau S). Fourth, transfer efficiency variations affect detection; optimize voltage and time for PVDF membranes and verify with reversible protein stains post-transfer. Fifth, antibody handling inconsistencies impact sensitivity; maintain consistent dilutions, avoid repeated freeze-thaw cycles, and prepare fresh working solutions. Sixth, detection system variability influences results; use the same ECL reagent lot and exposure method across experiments. Finally, stripping and reprobing membranes can cause epitope loss; consider running duplicate gels instead. Implement a detailed laboratory protocol with standardized positive controls and batch-prepare buffers to minimize experiment-to-experiment variations.

How can I determine the optimal antibody concentration and incubation conditions for SPBC119.16c antibody in various applications?

Determining optimal SPBC119.16c antibody conditions requires systematic titration across applications. For Western blotting, prepare a dilution series (1:250, 1:500, 1:1000, 1:2000, 1:5000) using identical protein samples. Incubate replicate blots at different temperatures (4°C, room temperature) and durations (1 hour, overnight). Quantify signal-to-noise ratios for each condition to identify optimal parameters . For immunoprecipitation, test antibody amounts (1 μg, 2.5 μg, 5 μg, 10 μg) per standardized lysate volume and vary incubation times (2 hours, 4 hours, overnight). Analyze pull-down efficiency by Western blot. For ChIP experiments, test antibody amounts (2 μg, 5 μg, 10 μg, 15 μg) per chromatin preparation from fixed cell numbers (typically 1-5×10^7 cells) . Validate enrichment by qPCR at known binding sites versus control regions. For immunofluorescence, prepare slides with identical samples and test antibody dilutions (1:50, 1:100, 1:200, 1:500) with different incubation protocols (1 hour at room temperature vs. overnight at 4°C). Document conditions that maximize specific signal while minimizing background for each application, creating a reference table for future experiments.

What strategies can I employ when SPBC119.16c antibody shows cross-reactivity with other proteins?

When SPBC119.16c antibody exhibits cross-reactivity, employ multiple strategies to improve specificity. First, perform more stringent blocking using 5% BSA instead of milk and increase blocking time to 2 hours at room temperature. Second, modify washing conditions by increasing wash buffer stringency (add 0.1-0.3M NaCl and increase Tween-20 to 0.2%) and extend washing times to 15 minutes per wash with at least 5 washes. Third, further dilute the primary antibody to reduce non-specific binding while maintaining overnight incubation at 4°C to preserve specific interactions. Fourth, pre-adsorb the antibody with total protein lysate from a SPBC119.16c deletion strain to remove antibodies binding to cross-reactive epitopes. Fifth, confirm band identity using genetic approaches by comparing Western blots from wild-type, deletion, and overexpression strains. Sixth, consider alternative detection methods like immunoprecipitation followed by mass spectrometry to validate antibody targets . Finally, if cross-reactivity persists, explore epitope-tagged versions of SPBC119.16c and use highly specific tag antibodies as an alternative approach to study the protein of interest.

How can SPBC119.16c antibody be used to investigate protein involvement in the cell cycle checkpoint pathways?

To investigate SPBC119.16c involvement in cell cycle checkpoint pathways, design experiments that integrate antibody-based detection with genetic and cellular perturbations. First, synchronize S. pombe cultures at different cell cycle phases and use Western blotting with SPBC119.16c antibody to track protein expression and modification patterns throughout the cycle . Second, induce checkpoint activation using genotoxic agents (hydroxyurea, methyl methanesulfonate) or spindle poisons (thiabendazole) and monitor SPBC119.16c levels, modifications, and localization changes in response to these stresses. Third, perform co-immunoprecipitation experiments with SPBC119.16c antibody followed by Western blotting for known checkpoint proteins (such as components of the CDK/cyclin complexes or PP2A phosphatase) to identify physical interactions . Fourth, combine these approaches with genetic analysis using checkpoint mutants (particularly in the Greatwall-Endosulfine-PP2A/B55 pathway) to establish epistatic relationships. Fifth, use chromatin immunoprecipitation to determine if SPBC119.16c associates with specific genomic regions during checkpoint activation. These methodological approaches will reveal whether SPBC119.16c functions as a checkpoint mediator, effector, or regulator in response to cellular stress.

What insights can be gained by studying SPBC119.16c localization during various cellular stresses?

Studying SPBC119.16c localization during cellular stresses provides insights into its functional roles in stress response pathways. Implement immunofluorescence microscopy using SPBC119.16c antibody in combination with subcellular markers to track protein redistribution. Expose S. pombe cultures to diverse stressors: oxidative stress (H₂O₂), heat shock (42°C), nutrient limitation (nitrogen or glucose deprivation), osmotic stress (sorbitol or KCl), and DNA damage (UV irradiation or phleomycin) . Fix cells at multiple timepoints post-stress (5, 15, 30, 60, 120 minutes) and process for immunofluorescence. Co-stain with DAPI and markers for cellular compartments (mitochondria, endoplasmic reticulum, Golgi, vacuoles) to determine precise localization patterns. Quantify changes in nuclear-cytoplasmic distribution, formation of stress granules or aggregates, and co-localization with stress response factors. Complement imaging data with biochemical fractionation and Western blotting to confirm redistribution between soluble and membrane-bound pools. Correlate localization changes with protein modifications detected by phospho-specific antibodies or mobility shifts. These approaches reveal whether SPBC119.16c undergoes stimulus-dependent translocation indicative of specific stress response functions.

How can SPBC119.16c antibody be used to investigate protein interactions with the Ino80 chromatin remodeling complex?

To investigate potential interactions between SPBC119.16c and the Ino80 chromatin remodeling complex, implement a multi-faceted approach using antibody-based techniques. Begin with reciprocal co-immunoprecipitation experiments using SPBC119.16c antibody and antibodies against Ino80 complex components (particularly Ies6 and Iec1, which have been shown to affect centromeric silencing) . Analyze precipitates by Western blotting and mass spectrometry to identify stable interactions. Perform ChIP-Seq experiments using SPBC119.16c antibody to determine genomic binding sites and compare these with known Ino80 complex binding profiles . Look for overlapping enrichment patterns, particularly at centromeric regions where the Ino80 complex influences CENP-A chromatin. Use sequential ChIP (Re-ChIP) to determine if SPBC119.16c and Ino80 components co-occupy the same genomic loci simultaneously. Complement these approaches with genetic interaction studies comparing phenotypes of single and double mutants of SPBC119.16c and Ino80 complex members. Finally, assess functional consequences by measuring effects on centromeric silencing, chromosome segregation, and TBZ sensitivity when SPBC119.16c is deleted or overexpressed in wild-type versus ies6Δ or iec1Δ backgrounds .

What experimental approaches can determine if SPBC119.16c is regulated by the Greatwall-Endosulfine-PP2A/B55 pathway?

To determine if SPBC119.16c is regulated by the Greatwall-Endosulfine-PP2A/B55 pathway, implement multiple experimental approaches. First, analyze SPBC119.16c phosphorylation status in wild-type versus mutants of this pathway (greatwall kinase mutant, endosulfine mutant, and PP2A/B55 mutant) using phosphate-affinity gel electrophoresis (Phos-tag) followed by Western blotting with SPBC119.16c antibody . Second, perform in vitro kinase and phosphatase assays using purified Greatwall, CDK/cyclin complexes, and PP2A/B55 with immunoprecipitated SPBC119.16c as substrate, followed by mass spectrometry to identify modification sites . Third, use genetic approaches by creating double mutants of SPBC119.16c with components of this pathway and assess phenotypes related to G1 arrest, cell differentiation, and nitrogen starvation response . Fourth, perform co-immunoprecipitation experiments using SPBC119.16c antibody to identify physical interactions with pathway components. Fifth, examine if SPBC119.16c localization changes in response to pathway perturbation using immunofluorescence microscopy. Sixth, conduct quantitative Western blot analysis to determine if SPBC119.16c protein levels are regulated by this pathway under different growth conditions. These approaches will reveal whether SPBC119.16c is a direct substrate, interacting partner, or functionally related component of the Greatwall-Endosulfine-PP2A/B55 regulatory network.